Stage FocusSeries B+
GeographyGlobal
TypeVC
Last Activity—
Industry Focus
Industries
Biotech
Technical BenchLimited
Investor TypeGeneralist
ExposureMinimal DeepTech Investments
Bio
Viking Global Investors manages more than $55 billion in assets, but it's fundamentally a hedge fund manager rather than a venture capital firm. The core business is long/short equity strategies across public markets, with multiple fund vehicles: Viking Global Equities (long/short), Viking Long (long-only), Viking Global Opportunities (public/private hybrid), Viking Structured Capital (credit), an...
Similar Funds
AstraZeneca Ventures
Cambridge, United Kingdom
GeneralistBiotechMedTechSeries ASeries B+
Bayern Kapital
DeepTech NativeBiotechSeedSeries A
BGF
London, United Kingdom
GeneralistBiotechClimate TechAdvanced MaterialsSeedSeries A
Bold Capital Partners
Santa Monica, United States
Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Bristol-Myers Squibb (Strategic Investments)
New York, United States
GeneralistBiotechMedTechAI InfrastructureSeries ASeries B+
British Patient Capital
London, United Kingdom
GeneralistBiotechAI InfrastructureClimate TechSeries ASeries B+